GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
130 hedge funds and large institutions have $772M invested in Genomic Health, Inc. in 2016 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 51 increasing their positions, 36 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $741M → $772M (+$31.5M)
98% less call options, than puts
Call options by funds: $6K | Put options by funds: $373K
Holders
130
Holding in Top 10
2
Calls
$6K
Puts
$373K
Top Buyers
| 1 | +$7M | |
| 2 | +$5.18M | |
| 3 | +$1.94M | |
| 4 |
CCMH
Cornerstone Capital Management Holdings
New York
|
+$1.93M |
| 5 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
+$1.48M |
Top Sellers
| 1 | -$8.78M | |
| 2 | -$5.61M | |
| 3 | -$5.51M | |
| 4 |
VAM
Visium Asset Management
New York
|
-$3.77M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$2.82M |